Tech Company Financing Transactions

StrideBio Funding Round

Hatteras Venture Partners, Alexandria Venture Investments and Takeda Ventures joined a $15.7 million Series A funding round for StrideBio. The round was recorded on 6/14/2018.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

5 Laboratory Dr. 1200
Research Triangle Park, NC 27709
USA

Phone

984-213-7300

Website

www.stridebio.com

Email Address

[email protected]

Overview

StrideBio, Inc. is a gene therapy company focused on creating and developing novel adeno-associated viral (AAV) vector technologies. Our STRucture Inspired DEsign approach holds the potential to generate unique AAV capsids capable of overcoming the challenges of pre-existing neutralizing antibodies in patients.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Sapan Shah

        

Chief Operating Officer

William Monteith

        

Chief Scientific Officer

Aravind Asokan

        

Co-Founder

Mavis Agbandje

        

Co-Founder

Patrick Ritschel

        

VP - Bus. Development

Maritza McIntyre

        

VP - Finance

Robert Hughes

        

VP - Operations

Ariane Hamaide

        

Browse more venture capital transactions:

Prev: 6/14/2018: FullContact venture capital transaction
Next: 6/14/2018: Opendoor venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary